Lymphadenopathy Diagnosis and Analysis
Lymphadenopathy Diagnosis and Analysis is a research topic within Surgery. Science Explorer counts 5.3k research works in it since 1950. 12.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the analysis, diagnosis, and management of Kikuchi-Fujimoto Disease, particularly in pediatric patients and its association with systemic lupus erythematosus. It also explores the relationship between lymphadenopathy and COVID-19 vaccination, as well as the use of fine needle aspiration biopsy and FDG PET/CT in diagnosing and managing the disease.
- Kikuchi-Fujimoto Disease
- Lymphadenopathy
- COVID-19 Vaccine
- Pediatric
- Diagnosis
- Management
- Fine Needle Aspiration Biopsy
- Systemic Lupus Erythematosus
- Histiocytic Necrotizing Lymphadenitis
- FDG PET/CT
- Research works
- 5.3k fractional, since 1950
- In the world top 10%
- 656 per year above
- Top-10% rate
- 12.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +64% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Lymphadenopathy Diagnosis and Analysis research?
By volume, the United States and India publish the most (209 and 142 works in 2022–2025).
By volume, 2022–2025
- 1 United States 209 works
- 2 India 142 works
- 3 China 125 works
- 4 Japan 69 works
- 5 Türkiye 54 works
- 6 Italy 50 works
- 7 United Kingdom 46 works
- 8 Germany 41 works
- 9 Spain 30 works
- 10 South Korea 27 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Lymphadenopathy Diagnosis and Analysis research?
By volume in 2022–2025, Sağlık Bilimleri Üniversitesi publishes the most Lymphadenopathy Diagnosis and Analysis research, followed by All India Institute of Medical Sciences and Institute of Medical Sciences.
By volume, 2022–2025
- 1 Sağlık Bilimleri ÜniversitesiTürkiye 7 works
- 2 All India Institute of Medical SciencesIndia 6 works
- 3 Institute of Medical SciencesIndia 4 works
- 4 The University of Texas MD Anderson Cancer CenterUnited States 4 works
- 5 Post Graduate Institute of Medical Education and ResearchIndia 3 works
- 6 Memorial Sloan Kettering Cancer CenterUnited States 3 works
- 7 China Medical UniversityChina 3 works
- 8 Baylor College of MedicineUnited States 3 works
- 9 Massachusetts General HospitalUnited States 3 works
- 10 Government Medical CollegeIndia 3 works
Who are the leading researchers in Lymphadenopathy Diagnosis and Analysis?
The most-cited researchers publishing on Lymphadenopathy Diagnosis and Analysis include Erika Ota and John F. Thompson.
- 1 Erika Ota Japan 2.5k citations
- 2 John F. Thompson Australia 2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Lymphadenopathy Diagnosis and Analysis research done?
The largest centres of Lymphadenopathy Diagnosis and Analysis research in 2022–2025 are Istanbul (Türkiye), Beijing (China), New Delhi (India) and Tokyo (Japan).
Largest cities, 2022–2025
Is Lymphadenopathy Diagnosis and Analysis research growing?
Output in 2018–2022 was 64% higher than in 2013–2017, peaking in 2022. The fastest-growing topics are Lymphadenopathy Diagnosis and Analysis.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.